Jnana Therapeutics
Latest round
- Series C
Last raised
- Nov 2022
Total raised
- $155M
Investors
- 8
About Jnana Therapeutics
Jnana Therapeutics Inc.Founded in 2017, Jnana Therapeutics Inc. operates out of Boston, US, concentrating on drug discovery processes., Ltd. acquired Jnana for USD 800 mn.Jnana Therapeutics focuses on innovative drug discovery through its proprietary RAPID platform, which is designed to develop small molecule medicines for a variety of therapeutic targets with enhanced speed and efficiency. The company's primary therapeutic areas include phenylketonuria (PKU) and a range of immune-mediated diseases, addressing significant unmet medical needs. Their chemoproteomics approach enables the identification of unique binding sites on validated protein targets, facilitating the rapid development of new therapeutic candidates. Jnana's sophisticated platform aims to streamline the drug discovery process, ultimately benefiting patients across diverse geographical markets including North America, Europe, and parts of Asia where these diseases are prevalent.Jnana Therapeutics generates revenue through strategic partnerships and collaborations focused on the pharmaceutical sector. The company typically engages in B2B transactions, where it partners with larger pharmaceutical firms to co-develop therapies and share the associated financial risks and rewards. Product offerings, particularly the pipeline therapies derived from their RAPID platform, form the basis of these partnerships, allowing clients to access groundbreaking treatments developed using Jnana's technology. Revenue streams are structured around milestone payments, royalties on future sales, or upfront payments associated with licensing agreements., Ltd. agreed to acquire Jnana Therapeutics Inc. for USD 800 mn, strengthening Otsuka's R&D presence in the Boston biocluster. This acquisition may bolster Jnana's capabilities to launch upcoming products targeting unmet medical needs in the pharmaceutical market.
Who invested in Jnana Therapeutics
8 investors across 3 rounds
See all investors in Jnana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jnana Therapeutics
Who invested in Jnana Therapeutics?
Jnana Therapeutics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jnana Therapeutics raised?
Jnana Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Jnana Therapeutics last raise money?
Jnana Therapeutics's most recent round on record is a Series C, in Nov 2022.
What does Jnana Therapeutics do?
Jnana Therapeutics is a biotechnology company.
Where is Jnana Therapeutics headquartered?
Jnana Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Jnana Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Jnana Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Jnana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.